BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21750859)

  • 1. Rho-kinase regulates thrombin-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Kato K; Otsuka T; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
    Int J Mol Med; 2011 Oct; 28(4):653-8. PubMed ID: 21750859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of Rho-kinase in prostaglandin F2alpha-stimulated interleukin-6 synthesis via p38 mitogen-activated protein kinase in osteoblasts.
    Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):27-32. PubMed ID: 18586382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of Rho-kinase in prostaglandin D2-induced interleukin-6 synthesis in osteoblasts.
    Tokuda H; Takai S; Matsushima-Nishiwaki R; Hanai Y; Adachi S; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):41-6. PubMed ID: 18771907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rho-kinase limits FGF-2-stimulated VEGF release in osteoblasts.
    Natsume H; Tokuda H; Adachi S; Takai S; Matsushima-Nishiwaki R; Kato K; Minamitani C; Niida S; Mizutani J; Kozawa O; Otsuka T
    Bone; 2010 Apr; 46(4):1068-74. PubMed ID: 20114091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Rho-kinase in prostaglandin E(1)-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblast-like MC3T3-E1 cells.
    Adachi S; Tokuda H; Matsushima-Nishiwaki R; Kato K; Natsume H; Minamitani C; Mizutani J; Otsuka T; Kozawa O
    Prostaglandins Other Lipid Mediat; 2009 Nov; 90(1-2):1-6. PubMed ID: 19524699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho-kinase regulates endothelin-1-stimulated IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Tokuda H; Hanai Y; Matsushima-Nishiwaki R; Yamauchi J; Doi T; Harada A; Takai S; Kozawa O
    Biochem Biophys Res Commun; 2007 Nov; 362(4):799-804. PubMed ID: 17825250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase inhibitors decrease TGF-beta-stimulated VEGF synthesis through stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
    Kuno M; Takai S; Matsushima-Nishiwaki R; Minamitani C; Mizutani J; Otsuka T; Harada A; Adachi S; Kozawa O; Tokuda H
    Biochem Pharmacol; 2009 Jan; 77(2):196-203. PubMed ID: 18996357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of AMP-activated protein kinase in thrombin-stimulated interleukin 6 synthesis in osteoblasts.
    Tokuda H; Kato K; Natsume H; Kondo A; Kuroyanagi G; Matsushima-Nishiwaki R; Ito Y; Otsuka T; Kozawa O
    J Mol Endocrinol; 2012 Aug; 49(1):47-55. PubMed ID: 22645249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSP90 inhibitors strengthen extracellular ATP-stimulated synthesis of interleukin-6 in osteoblasts: Amplification of p38 MAP kinase.
    Hioki T; Tokuda H; Nakashima D; Fujita K; Kawabata T; Sakai G; Kim W; Tachi J; Tanabe K; Matsushima-Nishiwaki R; Otsuka T; Iida H; Kozawa O
    Cell Biochem Funct; 2021 Jan; 39(1):88-97. PubMed ID: 32567086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP90 inhibitors potentiate PGF2α-induced IL-6 synthesis via p38 MAP kinase in osteoblasts.
    Fujita K; Tokuda H; Kuroyanagi G; Yamamoto N; Kainuma S; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
    PLoS One; 2017; 12(5):e0177878. PubMed ID: 28542188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rho-kinase limits BMP-4-stimulated osteocalcin synthesis in osteoblasts: regulation of the p38 MAP kinase pathway.
    Kondo A; Tokuda H; Matsushima-Nishiwaki R; Kuroyanagi G; Yamamoto N; Mizutani J; Kozawa O; Otsuka T
    Life Sci; 2014 Feb; 96(1-2):18-25. PubMed ID: 24368139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
    Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
    FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C.
    Miwa M; Kozawa O; Tokuda H; Uematsu T
    Endocrinology; 1999 Nov; 140(11):5120-5. PubMed ID: 10537140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
    Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
    Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP-activated protein kinase inhibitor decreases prostaglandin F2α-stimulated interleukin-6 synthesis through p38 MAP kinase in osteoblasts.
    Kondo A; Otsuka T; Kato K; Natsume H; Kuroyanagi G; Mizutani J; Ito Y; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Int J Mol Med; 2012 Dec; 30(6):1487-92. PubMed ID: 23064268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of Rho-kinase in sphingosine 1-phosphate-stimulated HSP27 induction in osteoblasts.
    Minamitani C; Otsuka T; Takai S; Matsushima-Nishiwaki R; Adachi S; Hanai Y; Mizutani J; Tokuda H; Kozawa O
    Int J Mol Med; 2009 Jul; 24(1):77-82. PubMed ID: 19513538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
    Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
    Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
    Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
    Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
    Yamamoto N; Otsuka T; Kuroyanagi G; Kondo A; Kainuma S; Nakakami A; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
    Prostaglandins Other Lipid Mediat; 2015; 116-117():57-63. PubMed ID: 25677506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of p44/p42 MAP kinase in insulin-like growth factor-I-induced alkaline phosphatase activity in osteoblast-like-MC3T3-E1 cells.
    Hanai Y; Tokuda H; Ishisaki A; Matsushima-Nishiwaki R; Nakamura N; Yoshida M; Takai S; Ohta T; Kozawa O
    Mol Cell Endocrinol; 2006 Jun; 251(1-2):42-8. PubMed ID: 16616413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.